We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pharmacyclics Initiates Phase 1 Clinical Trial of Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma

News   Apr 15, 2009

 
Pharmacyclics Initiates Phase 1 Clinical Trial of Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma
 
 
 

RELATED ARTICLES

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

Topical Immunotherapy Lowers Risk of Skin Cancer

News

A combination of two topical creams already shown to clear precancerous skin lesions from sun-damaged skin also lowers the risk that patients will later develop squamous cell carcinoma of the skin.

READ MORE

Discovering the Parameters That Govern the Encapsulation of Drugs

News

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE